Nontraumatic intracerebral hemorrhage. Nontraumatic intracerebral hemorrhage
Conditions
Interventions
Intervention 1: In the intervention group, in addition to standard treatment, Tranexamic Acid (manufactured by Raha Pharmaceutical Company) will be administered at a dose modified based on the patient
Sponsors
Oroumia University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Age = 18 years Diagnosis of spontaneous intracerebral hemorrhage (ICH) confirmed by initial brain CT scan Admission to the emergency department Hemodynamic stability after initial supportive management Provision of written informed consent by the patient or legal guardian
Exclusion criteria
Exclusion criteria: Urgent need for surgical intervention for hematoma evacuation Intracerebral hemorrhage secondary to trauma, aneurysm, malignancy, or structural brain lesions Pregnancy or breastfeeding Known coagulation disorders or use of uncontrollable anticoagulant therapy Moderate to severe renal failure History of thrombosis or active thromboembolic disease Hemodynamic instability despite initial therapeutic interventions Inability to obtain informed consent from the patient or legal guardian due to clinical or legal reasons
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| (Intracerebral Hemorrhage Volume). Timepoint: CT scan and calculation of bleeding volume will be performed at baseline, 48 hours after admission, and on the seventh day after study entry. Method of measurement: The volume of intracerebral hemorrhage is calculated using a brain CT scan and based on the standard ABC/2 formula. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Fatemeh Hamzeh
Oroumia University of Medical Sciences
Outcome results
None listed